This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1jzq

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1jzq.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1jzq.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1jzq| PDB=1jzq | SCENE= }}
{{STRUCTURE_1jzq| PDB=1jzq | SCENE= }}
-
'''Isoleucyl-tRNA synthetase Complexed with Isoleucyl-adenylate analogue'''
+
===Isoleucyl-tRNA synthetase Complexed with Isoleucyl-adenylate analogue===
-
==Overview==
+
<!--
-
An analogue of isoleucyl-adenylate (Ile-AMS) potently inhibits the isoleucyl-tRNA synthetases (IleRSs) from the three primary kingdoms, whereas the antibiotic mupirocin inhibits only the eubacterial and archaeal IleRSs, but not the eukaryotic enzymes, and therefore is clinically used against methicillin-resistant Staphylococcus aureus. We determined the crystal structures of the IleRS from the thermophilic eubacterium, Thermus thermophilus, in complexes with Ile-AMS and mupirocin at 3.0- and 2.5-A resolutions, respectively. A structural comparison of the IleRS.Ile-AMS complex with the adenylate complexes of other aminoacyl-tRNA synthetases revealed the common recognition mode of aminoacyl-adenylate by the class I aminoacyl-tRNA synthetases. The Ile-AMS and mupirocin, which have significantly different chemical structures, are recognized by many of the same amino acid residues of the IleRS, suggesting that the antibiotic inhibits the enzymatic activity by blocking the binding site of the high energy intermediate, Ile-AMP. In contrast, the two amino acid residues that concomitantly recognize Ile-AMS and mupirocin are different between the eubacterial/archaeal IleRSs and the eukaryotic IleRSs. Mutagenic analyses revealed that the replacement of the two residues significantly changed the sensitivity to mupirocin.
+
The line below this paragraph, {{ABSTRACT_PUBMED_11584022}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 11584022 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_11584022}}
==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Rsgi]]
[[Category: Rsgi]]
[[Category: Structural genomic]]
[[Category: Structural genomic]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 22:07:12 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 06:04:07 2008''

Revision as of 03:04, 28 July 2008

Image:1jzq.png

Template:STRUCTURE 1jzq

Isoleucyl-tRNA synthetase Complexed with Isoleucyl-adenylate analogue

Template:ABSTRACT PUBMED 11584022

About this Structure

1JZQ is a Single protein structure of sequence from Thermus thermophilus. Full crystallographic information is available from OCA.

Reference

Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase., Nakama T, Nureki O, Yokoyama S, J Biol Chem. 2001 Dec 14;276(50):47387-93. Epub 2001 Oct 2. PMID:11584022

Page seeded by OCA on Mon Jul 28 06:04:07 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1jzq"
Personal tools